Biodel Inc. (BIOD)'s Diabetes Drug VIAject Meets Goals
Biodel Inc. (BIOD)'s Diabetes Drug VIAject Meets Goals
9/8/2008
LONDON, Sept 8 (Reuters) - Two studies have shown Biodel Inc's diabetes drug VIAject is as effective as Eli Lilly and Co's Humulin at controlling blood sugar level in people with diabetes, the company said on Monday.
Latest Commentary